Skip to Content

Lipid Screen, CVD Assessment Advised in Endocrine Disorders

FRIDAY, Oct. 30, 2020 -- Lipid screening and cardiovascular risk assessment should be performed for all patients with endocrine disorders, according to an Endocrine Society clinical practice guideline published in the December issue of the Journal of Clinical Endocrinology & Metabolism.

Connie B. Newman, M.D., from the New York University Grossman School of Medicine in New York City, and colleagues reviewed data on dyslipidemia and atherosclerotic cardiovascular disease risk in patients with endocrine disorders.

The authors recommend screening and cardiovascular disease risk assessment, including a lipid panel for assessment of triglyceride levels and calculating low-density lipoprotein cholesterol. Pharmacologic treatment is recommended as adjunct to diet and exercise to prevent pancreatitis in adults with fasting triglyceride levels >500 mg/dL. Statin therapy is recommended in addition to lifestyle modification to reduce cardiovascular risk in adults with type 2 diabetes and other cardiovascular risk factors. Statin therapy is suggested for patients with type 1 diabetes who are age 40 years or older, with diabetes duration >20 years, microvascular complications, chronic kidney disease in stages 1 to 4, obesity, high triglycerides and low high-density lipoprotein cholesterol, or diabetic retinopathy. Before treatment with lipid-lowering medication, hypothyroidism should be ruled out in patients with hyperlipidemia.

"This guideline is the first of its kind," Newman said in a statement. "We hope that it will make a lipid panel and cardiovascular risk evaluation routine in adults with endocrine diseases and cause a greater focus on therapies to reduce heart disease and stroke."

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: October 2020

Read this next

Oily Fish Consumption Tied to Lower Type 2 Diabetes Risk

FRIDAY, Jan. 22, 2021 -- Consumption of oily fish, but not nonoily fish, is associated with a lower risk for type 2 diabetes (T2D), according to a study published online Jan. 11...

Green-Mediterranean Diet Boosts Intrahepatic Fat Loss

WEDNESDAY, Jan. 20, 2021 -- A green-Mediterranean (MED) diet, enriched with green plants and polyphenols, can reduce intrahepatic fat (IHF) loss more than other healthy eating...

Default Opt-Out of Cardiac Rehabilitation Increases Referrals

TUESDAY, Jan. 19, 2021 -- For inpatients with ischemic heart disease, redesign of decision pathways from default opt-in to opt-out of cardiac rehabilitation (CR) results in a...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.